Profile for Japan Patent: 5566102
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 5566102
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 7,682,633 | Jun 19, 2027 | Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride |
| 7,682,634 | Jun 19, 2027 | Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride |
| 8,158,156 | Jun 19, 2027 | Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride |
| 8,846,104 | Jun 19, 2027 | Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride |
| 8,877,247 | Jun 19, 2027 | Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
